Patent application number | Description | Published |
20090005661 | Non-invasive blood component measuring device and non-invasive blood component measuring method - A non-invasive blood component measuring device comprising: a light source section for irradiating a light to a blood vessel through a skin; an imaging section for imaging the irradiated blood vessel through the skin; and a controller, including a memory under control of a processor, the memory storing instructions enabling the processor to carry out operations, comprising: creating a concentration profile based on an image obtained by imaging the blood vessel with the imaging section; calculating a blood component concentration based on the concentration profile; acquiring a shape feature of the concentration profile; and correcting the blood component concentration based on the shape feature of the concentration profile is disclosed. A non-invasive blood component measuring method is also disclosed. | 01-01-2009 |
20090246809 | METHOD OF SUPPORTING A DIAGNOSIS OF A RISK OF CANCER RECURRENCE, AND A DEVICE OF SUPPORTING A DIAGNOSIS OF A RISK OF CANCER RECURRENCE - A method of supporting a diagnosis of a risk of cancer recurrence is disclosed. The method provides a new determining value a recurrence risk score (RRS) which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The risk of cancer recurrence is judged by comparing the RRS with a predetermined threshold level for RRS. | 10-01-2009 |
20090248316 | METHOD FOR SUPPORTING A DIAGNOSIS OF AN EFFECT OF A TREATMENT BY USING ANTHRACYCLINE ANTICANCER DRUGS AND A DEVICE FOR SUPPORTING A DIAGNOSIS FOR AN EFFECT OF A TREATMENT BY USING ANTHRACYCLINE ANTICANCER DRUGS - A method of supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs is disclosed. The method provides a new value for judging an effect, a judgment score, which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The effect of the treatment by using anthracycline anticancer drugs is judged by comparing the judgment score with a predetermined threshold level. | 10-01-2009 |
20100130841 | NONINVASIVE LIVING BODY MEASUREMENT APPARATUS AND NONINVASIVE LIVING BODY MEASUREMENT METHOD - An easily wearable noninvasive living body measurement apparatus is provided. The noninvasive living body measurement apparatus ( | 05-27-2010 |
20110104744 | CELL ANALYZING APPARATUS AND CELL ANALYZING METHOD - A cell analyzing apparatus, comprising: a parameter obtaining section for obtaining a characteristic parameter from a cell in a measurement sample; an imaging section for capturing an image of the cell in the measurement sample; an analyzing section for counting a cell in which the characteristic parameter meets a predetermined requirement among the cells in the measurement sample as a counting target and generating output data based on a counting result; a display section for displaying an image of the cell meeting the predetermined requirement and the output data; and an input section for receiving an instruction to specify the image displayed on the display section, wherein the analyzing section excludes a cell relevant to the specified image from the counting target and regenerates the output data is disclosed. A cell analyzing method is also disclosed. | 05-05-2011 |